Effect of topical mirtazapine on eczema
Phase 3
- Conditions
- Atopic dermatitis.Other atopic dermatitis
- Registration Number
- IRCT2015071722965N3
- Lead Sponsor
- Vice chancellor for research, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Age between 18-65 years old; Moderate to severe eczema; Patients who less than 25% of their skin is involved; Discountinue of glucocorticoid agents 4 weeks prior to the investigation; Discountinue of anti puritis agents 1 week prior to the investigation
Exclusion criteria: Age less than 18 years old; Patients with inflammatory skin disease; Pregnant woman
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eczema. Timepoint: 5 and 10 days following of treatment. Method of measurement: Visual Analogue Score.
- Secondary Outcome Measures
Name Time Method